Seer, Inc. Class A Common Stock
SEER
SEER: Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across the proteome.
moreShow SEER Financials
Recent trades of SEER by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SEER's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Systems and methods for sample preparation, data generation, and protein corona analysis Apr. 18, 2023
-
Patent Title: Compositions, methods and systems for protein corona analysis and uses thereof Aug. 30, 2022
-
Patent Title: Systems and methods for discovery and analysis of markers Nov. 05, 2019
-
Patent Title: Variable step tracking Oct. 27, 2015
-
Patent Title: Systems and methods for chemical sampling in particulate laden gaseous environments Sep. 25, 2012
-
Patent Title: Apparatus, system, and method for improved power utilization in a gas chromatography sensor Oct. 05, 2010
-
Patent Title: Apparatus, system, and method for broad spectrum chemical detection Jun. 22, 2010
-
Patent Title: Apparatus, system, and method for low cost high resolution chemical detection Jan. 19, 2010
Federal grants, loans, and purchases
Followers on SEER's company Twitter account
Number of mentions of SEER in WallStreetBets Daily Discussion
Recent insights relating to SEER
Recent picks made for SEER stock on CNBC
ETFs with the largest estimated holdings in SEER
Flights by private jets registered to SEER